42 CFR §428.404

1. (a)General. CMS will establish a method and process for a manufacturer of the Part D rebatable drug to:
   1. (1)Access the Rebate Report as set forth in §§ 428.401 and 428.402, including any report of a reconciled rebate amount as set forth in §§ 428.401 and 428.402;
   2. (2)Submit a Suggestion of Error as set forth in §§ 428.402(c) and 428.403; and
   3. (3)Pay a rebate amount as set forth in § 428.405.
2. (b)[Reserved]